Assessment of Interactions Between Intravenous Methamphetamine and Modafinil - 1
This trial is active, not recruiting.
|Sponsor||National Institute on Drug Abuse (NIDA)|
|Start date||March 2005|
|End date||March 2006|
|Trial size||16 participants|
|Trial identifier||NCT00265278, NIDA-CPU-0008-1|
The purpose of this study is to assess the potential interactions between intravenous methamphetamine and oral Modafinil.
|Endpoint classification||safety study|
|Intervention model||parallel assignment|
Subjective symptoms/Mood Effects
Male or female participants from 18 years up to 45 years old.
Inclusion Criteria: - normotensive - good physical and mental health - body mass index between 18 and 30 - if female, using an acceptable method of contraception and are not pregnant - able to give voluntary informed consent Exclusion Criteria: - Please contact site for further details
|Official title||Double-Blind, Placebo-Controlled Assessment of Interactions Between Intravenous Methamphetamine and Modafinil|
|Principal investigator||Reese Jones, M.D.|
|Description||The primary aims of this experiment are to determine if there are significant safety interactions between oral modafinil and intravenous methamphetamine. Safety will be assessed by measuring adverse events and cardiovascular responses of heart rate (HR), blood pressure (BP), and electrocardiogram (ECG) and stroke distance (ICG).|
Call for more information